RRML - Screening of a novel BRCA2 mutation by rapid in-house PCR-RFLP

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2016): 55%

Română English

Clarivate analytics (ISI) Impact factor

Advanced search

Top 10 downloaded articles
- October 2020 -
Romanian Review of Laboratory ... 17
High frequency of BRCA recurre... 16
Antibacterial and antitumor ac... 14
Troubleshootings in RNA extrac... 14
Metabolomic biomarkers of poly... 13
Carbapenemase Producing Entero... 10
Evaluation of oxidative stress... 10
The association of anthropomet... 10
Characterization of antibiotic... 9
Comparative Evaluation of RNAl... 9

Log in

Concept, Design & Programming
Dr. Adrian Man

Nr. 19(4)/2011

Screening of a novel BRCA2 mutation by rapid in-house PCR-RFLP

Lucian Negură, Doina Azoicăi, Mioara Matei, George Popoiu, Anca Negură


BRCA1 and BRCA2 are major cancer predisposition genes, responsible for a large percentage of hereditary breast and ovarian cancer (HBOC) families. The distribution of BRCA mutations has been studied in many populations, though only recently so in Romania. We started the first local oncogenetic study, searching for mutations of BRCA genes in HBOC families, by using mutation-specific PCR-based methods and dideoxy sequencing. We investigated 104 samples from familial (29 HBOC) and non-familial cancer cases (50 breast, 25 ovary), from North-Eastern Romania. Among the diversity of BRCA deleterious mutations, a novel BRCA2 mutation in exon 21, c.8680C>T, was identified. The T for C substitution creates a stop codon at position 2894, truncating the last C-terminal 525 amino acids of BRCA2 protein. The mutation is not yet stored in international databases. The mutation was firstly identified in a breast cancer predisposition family. We imagined a simple and rapid screening for c.8680C>T identification. This substitution creates an additional TaaI restriction site, allowing a quick identification of the mutation by PCR-RFLP and agarose gel electrophoresis. Rapid screening allowed the identification of the same mutation in a sporadic ovarian cancer patient. Our results could open the way for a population study to determine the frequency of c.8680C>T, its possible recurrence, and an eventual founder effect in Romania.

Keywords: Breast/ovarian cancer predisposition,HBOC families,BRCA genes,c.8680C>T mutation,PCR-RFLP.

  PDF Download full text PDF
(297 KB)
How to cite
Negură L, Azoicăi D, Matei M, Popoiu G, Negură A. Screening of a novel BRCA2 mutation by rapid in-house PCR-RFLP. Rev Romana Med Lab. 2011;19(4):333-9